Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability

Experimental Hematology

Volumn 33, Issue 8, 2005, Pages 935-943

  Sanchez Guijo, Fermin M ^a,b   Sanchez Abarca, Luis Ignacio ^a,b   Villaron, Eva ^a,b   Lopez Holgado, Natalia ^a,b   Alberca, Mercedes ^a,b   Vazquez, Lourdes ^a   Perez Simon, Jose A ^a,b   Lopez Fidalgo, Jesus ^c   Orfao, Alberto ^b,c   Caballero, Maria Dolores ^a   Del Cañizo, Maria Consuelo ^a,b   San Miguel, Jesus F ^a,b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b Centro de Investigacion del Cancer   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW; CELL CULTURE; CLINICAL ARTICLE; COMPARATIVE STUDY; ERYTHROID CELL; FLOW CYTOMETRY; FUNCTIONAL ASSESSMENT; GRANULOCYTE; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; LONG TERM CARE; MONOCYTE; PRIORITY JOURNAL; STEM CELL; STROMA CELL; T LYMPHOCYTE; TRANSPLANTATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; ERYTHROID PROGENITOR CELLS; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTE PRECURSOR CELLS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIVING DONORS; MALE; MIDDLE AGED; STROMAL CELLS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 22144446419     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2005.04.009     Document Type: Article

References (51)

1. D.C. Betticher, H. Huxol, R. Muller, B. Speck, and C. Nissen Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia Exp Hematol 21 1993 1517 1521
2. N. Novitzky, and R. Mohamed Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation Exp Hematol 23 1995 1661 1666
3. M. Podesta, G. Piaggio, and F. Frassoni Deficient reconstitution of early progenitors after allogeneic bone marrow transplantation Bone Marrow Transplant 19 1997 1011 1017
4. C. Selleri, J.P. Maciejewski, and G. De Rosa Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant Bone Marrow Transplant 23 1999 1029 1037
5. A.J. Barrett, and J. Adams A proliferative defect of human bone marrow after transplantation Br J Haematol 49 1981 159 164
6. P. Mauch, J. Ferrara, and S. Hellman Stem cell self-renewal considerations in bone marrow transplantation Bone Marrow Transplant 4 1989 601 607
7. I. Thornley, D.R. Sutherland, and R. Nayar Replicative stress after allogeneic bone marrow transplantation: changes in cycling of CD34+CD90+ and CD34+ Blood 97 2001 1876 1878
8. M. Galotto, G. Berisso, and L. Delfino Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients Exp Hematol 27 1999 1460 1466
9. E. O'Flaherty, R. Sparrow, and J. Szer Bone marrow stromal function from patients after bone marrow transplantation Bone Marrow Transplant 15 1995 207 212
10. V. Gupta, H.M. Lazarus, and A. Keating Myeloablative conditioning regimens for AML allografts: 30 years later Bone Marrow Transplant 32 2003 969 978
11. J.A. Perez-Simon, M. Diez-Campelo, and R. Martino Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation Blood 102 2003 1108 1113
12. J.A. Perez-Simon, D. Caballero, and M. Diez-Campelo Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation Leukemia 16 2002 1423 1431
13. J.A. Perez-Simon, M. Diez-Campelo, and R. Martino Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation Blood 102 2003 1108 1113
14. S. Gartner, and H.S. Kaplan Long-term culture of human bone marrow cells Proc Natl Acad Sci U S A 77 1980 4756 4759
15. M.Y. Gordon Plastic-adherent cells in human bone marrow generate long-term hematopoiesis in vitro Leukemia 8 1994 865 870
16. C. del Cañizo, N. Lopez, and D. Caballero Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation Bone Marrow Transplant 23 1999 901 905
17. J.W. Gratama, P. Menendez, J. Kraan, and A. Orfao Loss of CD34(+) hematopoietic progenitor cells due to washing can be reduced by the use of fixative-free erythrocyte lysing reagents J Immunol Methods 239 2000 13 23
18. P. Menendez, J.A. Perez-Simon, and M.V. Mateos Influence of the different CD34+ and CD34- cell subsets infused on clinical outcome after non-myeloablative allogeneic peripheral blood transplantation from human leucocyte antigen-identical sibling donors Br J Haematol 119 2002 135 143
19. P. Menendez, F. Prosper, and C. Bueno Sequential analysis of CD34+ and CD34- cell subsets in peripheral blood and leukapheresis products from breast cancer patients mobilized with SCF plus G-CSF and cyclophosphamide Leukemia 15 2001 430 439
20. P. Menendez, M.C. Del Canizo, and A. Orfao Immunophenotypic characteristics of PB-mobilised CD34+ hematopoietic progenitor cells J Biol Regul Homeost Agents 15 2001 53 61
21. D.C. Betticher, H. Huxol, R. Muller, B. Speck, and C. Nissen Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia Exp Hematol 21 1993 1517 1521
22. N. Novitzky, and R. Mohammed Alterations in the progenitor cell population follow recovery from myeloablative therapy and bone marrow transplantation Exp Hematol 25 1997 471 477
23. M. Podesta, G. Piaggio, and F. Frassoni Deficient reconstitution of early progenitors after allogeneic bone marrow transplantation Bone Marrow Transplant 19 1997 1011 1017
24. C. Selleri, J.P. Maciejewski, and G. De Rosa Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant Bone Marrow Transplant 23 1999 1029 1037
25. A.J. Barrett, and J. Adams A proliferative defect of human bone marrow after transplantation Br J Haematol 49 1981 159 164
26. P. Mauch, J. Ferrara, and S. Hellman Stem cell self-renewal considerations in bone marrow transplantation Bone Marrow Transplant 4 1989 601 607
27. P. Mauch, M. Rosenblatt, and S. Hellman Permanent loss in stem cell self renewal capacity following stress to the marrow Blood 72 1988 1193 1196
28. I. Thornley, D.R. Sutherland, and R. Nayar Replicative stress after allogeneic bone marrow transplantation: changes in cycling of CD34+ CD90+ and CD34+ Blood 97 2001 1876 1878
29. N.L. Lewis, M. Mullaney, and K.F. Mangan Measurable immune dysfunction and telomere attrition in long-term allogeneic transplant recipients Bone Marrow Transplant 33 2004 71 78
30. R.F. Wynn, M.A. Cross, and C. Hatton Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants Lancet 351 1998 178 181
31. E.S. de Pauw, S.A. Otto, and J.T. Wijnen Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion Br J Haematol 116 2002 491 496
32. I. Thornley, R. Sutherland, and R. Wynn Early hematopoietic reconstitution after clinical stem cell transplantation: evidence for stochastic stem cell behavior and limited acceleration in telomere loss Blood 99 2002 2387 2396
33. N. Awaya, K. Rupert, E. Bryant, and B. Torok-Storb Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation Exp Hematol 30 2002 937 942
34. J. Laver, S.C. Jhanwar, R.J. O'Reilly, and H. Castro-Malaspina Host origin of the human hematopoietic microenvironment following allogeneic bone marrow transplantation Blood 70 1987 1966 1968
35. P.J. Simmons, D. Przepiorka, E.D. Thomas, and B. Torok-Storb Host origin of marrow stromal cells following allogeneic bone marrow transplantation Nature 328 1987 429 432
36. N. Stute, B. Fehse, and J. Schroder Human mesenchymal stem cells are not of donor origin in patients with severe aplastic anemia who underwent sex-mismatched allogeneic bone marrow transplant J Hematother Stem Cell Res 11 2002 977 984
37. A. Banfi, G. Bianchi, M. Galotto, R. Cancedda, and R. Quarto Bone marrow stromal damage after chemo/radiotherapy: occurrence, consequences and possibilities of treatment Leuk Lymphoma 42 2001 863 870
38. M. Galotto, G. Berisso, and L. Delfino Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients Exp Hematol 27 1999 1460 1466
39. E. O'Flaherty, R. Sparrow, and J. Szer Bone marrow stromal function from patients after bone marrow transplantation Bone Marrow Transplant 15 1995 207 212
40. C. del Cañizo, N. Lopez, and D. Caballero Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation Bone Marrow Transplant 23 1999 901 905
41. M.C. del Cañizo, N. Lopez, and L. Vazquez Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery Haematologica 84 1999 511 516
42. L. Tauchmanova, B. Serio, and A. Del Puente Long-lasting bone damage detected by dual-energy x-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation J Clin Endocrinol Metab 87 2002 5058 5065
43. L. Tauchmanova, P. Ricci, and B. Serio Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation J Clin Endocrinol Metab 90 2005 627 634
44. E.M. Villaron, J. Almeida, and N. Lopez-Holgado Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation Haematologica 89 2004 1421 1427
45. J. Tanaka, M. Imamura, M. Kasai, M. Asaka, and B. Torok-Storb The role of accessory cells in allogeneic peripheral blood stem cell transplantation Int J Hematol 69 1999 70 74
46. H. van den Berg, M.J. van Tol, J.L. Waaijer, N.J. Oudeman-Gruber, and J.M. Vossen Study of possible correlations between in vitro growth of bone marrow stromal and hematopoietic precursor cells early after allogeneic bone marrow transplantation Exp Hematol 20 1992 184 191
47. G. Martinez-Jaramillo, E. Gomez-Morales, E. Sanchez-Valle, and H. Mayani Severe hematopoietic alterations in vitro, in bone marrow transplant recipients who develop graft-versus-host disease J Hematother Stem Cell Res 10 2001 347 354
48. T. Okamoto, A. Kanamaru, E. Kakishita, and K. Nagai Stromal fibroblastic and hematopoietic progenitors in patients with graft-versus-host disease (GVHD) Int J Hematol 54 1991 299 306
49. M.R. Jadus, and H.T. Wepsic The role of cytokines in graft-versus-host reactions and disease Bone Marrow Transplant 10 1992 1 14
50. J. Tanaka, M. Imamura, and M. Kasai The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease Bone Marrow Transplant 19 1997 571 576
51. Y. Hirayama, S. Sakamaki, and Y. Tsuji Thrombopoietin concentrations in peripheral blood correlated with platelet numbers in two patients with thrombocytopenia by chronic graft-versus-host disease Am J Hematol 73 2003 285 289